Back to Results
First PageMeta Content
Medicine / Health / Biology / Pharmacology / Biologic / Mucositis


Avaxia Biologic’s Barbara Fox Named One of Mass High Tech’s Women to Watch in 2012 LEXINGTON, Mass. – March 1, 2012 – Avaxia Biologics, Inc., a privately-held biotech company using its proprietary platform techno
Add to Reading List

Document Date: 2014-02-06 00:38:25

Open Document

File Size: 86,75 KB

Share Result on Facebook

City

LEXINGTON / Baltimore / /

Company

Avaxia Biologics Inc. / Recovery Pharmaceuticals / ImmuLogic Pharmaceutical Corp. / /

Facility

Bryn Mawr College / building Avaxia Biologics / University Maryland School / Fairmont Copley Plaza / /

IndustryTerm

platform technology / therapeutics for the treatment of gastrointestinal diseases / /

MedicalCondition

celiac disease / inflammatory bowel disease / GI acute radiation syndrome / metabolic diseases / oral mucositis / diabetes / obesity / both diseases / gastrointestinal diseases / /

MedicalTreatment

radiation / /

Organization

National Institute of Health / MIT / Bryn Mawr College / Division of Rheumatology / University Maryland School of Medicine / /

Person

Immunology / Barbara Fox / David Poorvin / /

Position

CEO / President and Chief Scientific Officer / Vice President / executive / innovative scientist / member of the Board of Directors / Associate Professor / Professor of Medicine / /

ProvinceOrState

Massachusetts / /

Technology

radiation / antibodies / platform technology / drug development / /

SocialTag